Skip to main content
Autobound logo
Pfizer8-K: Restructuring

Pfizer announces CFO transition on June 18, 2026, signaling potential financial strategy review.

Read at SEC EDGAR

What happened

A change in the Chief Financial Officer role is a major catalyst for reviewing financial strategies, processes, and technology stacks.

Source

SEC EDGARJun 18, 2026

Current report (Form 8-K)

Pfizer 8-K

Filing excerpt

Following the disclosure of Pfizer’s Chief Financial Officer transition announcement on June 18, 2026, Pfizer today is reaffirming its fiscal year 2026 guidance...

sec.gov/Archives/edgar/data/78003/000007800326000087/pfe-20260618.htmRead the full source

Other signals in this filing (1)

Extracted by Autobound

From the Signal API record
Signal
8-K: Restructuring

What this signalsFilings often name leadership changes, deals and spending plans.

Form
8-K
Fiscal year end
06/18
Filed
Jun 18, 2026

More from Pfizer

Company page →

More 8-K signals at other companies

The full record

From the Signal API record

Details

CIK
78003
Accession number
0000078003-26-000087
Timeframe
Immediate
Filing year
2026
Why it matters
Change management needs
Signal category
Workforce

Extraction

Confidence
High
Relevance
90%
Sentiment
Neutral
Detected
Jun 23, 2026
signal_type
sec-8k
signal_subtype
restructuring

Use this data

Get every 8-K signal for Pfizer and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Pfizer this week?”

    MCP setup guide

  2. Send it to your own tools

    The Signal API returns 8-K signals for any list of companies as JSON, for your CRM, warehouse or app.

    Signal API

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full sec-8k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Start Free1,000 free creditsUse it in Claude via MCP
Show the full JSONThe record on this page and the API request

GET /v1/signals/2774442f-8343-415e-b251-ba9702dc95c6 returns this record as JSON. POST /v1/companies/enrich returns every signal for pfizer.com.

{
  "signal_id": "2774442f-8343-415e-b251-ba9702dc95c6",
  "signal_type": "sec-8k",
  "signal_subtype": "restructuring",
  "detected_at": "2026-06-23T07:10:48.235+00:00",
  "company": {
    "name": "Pfizer",
    "domain": "pfizer.com"
  },
  "data": {
    "detail": "A change in the Chief Financial Officer role is a major catalyst for reviewing financial strategies, processes, and technology stacks. This creates a 90-day window of opportunity for vendors offering financial software, analytics platforms, and consulting services to engage with new leadership.",
    "metrics": {
      "timeframe": "immediate"
    },
    "summary": "Pfizer announces CFO transition on June 18, 2026, signaling potential financial strategy review.",
    "excerpts": "Following the disclosure of Pfizer’s Chief Financial Officer transition announcement on June 18, 2026, Pfizer today is reaffirming its fiscal year 2026 guidance...",
    "relevance": 0.9,
    "sentiment": "neutral",
    "confidence": "high",
    "source_url": "https://www.sec.gov/Archives/edgar/data/78003/000007800326000087/pfe-20260618.htm",
    "filing_date": "2026-06-18",
    "filing_year": 2026,
    "fiscal_year_end": "06/18",
    "sales_relevance": "Change management needs",
    "signal_category": "workforce"
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.